Graniteshares outlines positive case for healthcare sector as the global economy enters a more difficult period
Sign up to our free newsletters
Will Rhind, Founder and CEO at GraniteShares
Graniteshares 3x Long AstraZeneca ETP (3LAZ) delivered 41.1% in the year to 24th November 2021, compared to the AstraZeneca share price increasing by 18.8%
ETP provider GraniteShares, which offers a range of 3x short and 3x leveraged ETPs on popular UK, US, and French stocks, says the investment outlook for the healthcare sector is positive.
It says as we enter a more difficult environment, moving beyond rapid recovery and facing greater uncertainty, the healthcare sector may provide some opportunity for investors. Traditionally it has performed well in mid-cycle environments, which we currently face.
Will Rhind, CEO and founder of GraniteShares said: “Leading healthcare companies that are able to maintain earnings momentum through a period of slowing economic growth, may exhibit lower volatility and defensive growth characteristics. They can often deliver this because of the necessity of many of their products and services”.
“During the crisis, the sector has also made huge strides from a technological point of view, improving levels of efficiency and delivering new product innovations, which should help drive profitability.”
GraniteShares currently offers 54 exchange traded products (ETPs) listed on the London Stock Ex-change and 62 on Euronext. They consist of a suite of index ETPs tracking FAANG stocks and a suite of Short and Leveraged Single Stock Daily ETPs tracking some of the most popular companies in UK US and French markets. This includes 3x Long and 3X short AstraZeneca Daily ETPs (3LAZ and 3SAZ).
In the year to 24th November 2021, the AstraZeneca share price had increased by 18.8%, and the corresponding figure for 3x Long AstraZeneca Daily ETP (3LAZ) was 41.1%.
ETPs offer a pure way to gain exposure to top tech companies in the U.S. market. Indices are equally weighted and rebalanced quarterly.
Source: ETFWorld.co.uk
Subscribe to Our Newsletter
